Wisniewski T - Search Results

1

Clearance systems in the brain-implications for Alzheimer disease.

Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, Axel L, Rusinek H, Nicholson C, Zlokovic BV, Frangione B, Blennow K, Ménard J, Zetterberg H, Wisniewski T, de Leon MJ. Tarasoff-Conway JM, et al. Among authors: wisniewski t. Nat Rev Neurol. 2015 Aug;11(8):457-70. doi: 10.1038/nrneurol.2015.119. Epub 2015 Jul 21. Nat Rev Neurol. 2015. PMID: 26195256 Free PMC article. Review.

2

Infectivity of amyloid diseases.

Sigurdsson EM, Wisniewski T, Frangione B. Sigurdsson EM, et al. Among authors: wisniewski t. Trends Mol Med. 2002 Sep;8(9):411-3. doi: 10.1016/s1471-4914(02)02403-6. Trends Mol Med. 2002. PMID: 12223307

3

A safer vaccine for Alzheimer's disease?

Sigurdsson EM, Wisniewski T, Frangione B. Sigurdsson EM, et al. Among authors: wisniewski t. Neurobiol Aging. 2002 Nov-Dec;23(6):1001-8. doi: 10.1016/s0197-4580(02)00124-0. Neurobiol Aging. 2002. PMID: 12470795 Review.

4

Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesions.

Mackic JB, Bading J, Ghiso J, Walker L, Wisniewski T, Frangione B, Zlokovic BV. Mackic JB, et al. Among authors: wisniewski t. Vascul Pharmacol. 2002 Jun;38(6):303-13. doi: 10.1016/s1537-1891(02)00198-2. Vascul Pharmacol. 2002. PMID: 12529925

5

MRI assessment of neuropathology in a transgenic mouse model of Alzheimer's disease.

Helpern JA, Lee SP, Falangola MF, Dyakin VV, Bogart A, Ardekani B, Duff K, Branch C, Wisniewski T, de Leon MJ, Wolf O, O'Shea J, Nixon RA. Helpern JA, et al. Among authors: wisniewski t. Magn Reson Med. 2004 Apr;51(4):794-8. doi: 10.1002/mrm.20038. Magn Reson Med. 2004. PMID: 15065253 Free article.

6

An attenuated immune response is sufficient to enhance cognition in an Alzheimer's disease mouse model immunized with amyloid-beta derivatives.

Sigurdsson EM, Knudsen E, Asuni A, Fitzer-Attas C, Sage D, Quartermain D, Goni F, Frangione B, Wisniewski T. Sigurdsson EM, et al. Among authors: wisniewski t. J Neurosci. 2004 Jul 14;24(28):6277-82. doi: 10.1523/JNEUROSCI.1344-04.2004. J Neurosci. 2004. PMID: 15254082 Free PMC article.

7

Immunological and anti-chaperone therapeutic approaches for Alzheimer disease.

Wisniewski T, Frangione B. Wisniewski T, et al. Brain Pathol. 2005 Jan;15(1):72-7. doi: 10.1111/j.1750-3639.2005.tb00102.x. Brain Pathol. 2005. PMID: 15779239 Free PMC article. Review.

8

Plaque-associated overexpression of insulin-degrading enzyme in the cerebral cortex of aged transgenic tg2576 mice with Alzheimer pathology.

Leal MC, Dorfman VB, Gamba AF, Frangione B, Wisniewski T, Castaño EM, Sigurdsson EM, Morelli L. Leal MC, et al. Among authors: wisniewski t. J Neuropathol Exp Neurol. 2006 Oct;65(10):976-87. doi: 10.1097/01.jnen.0000235853.70092.ba. J Neuropathol Exp Neurol. 2006. PMID: 17021402

9

Vaccination of Alzheimer's model mice with Abeta derivative in alum adjuvant reduces Abeta burden without microhemorrhages.

Asuni AA, Boutajangout A, Scholtzova H, Knudsen E, Li YS, Quartermain D, Frangione B, Wisniewski T, Sigurdsson EM. Asuni AA, et al. Among authors: wisniewski t. Eur J Neurosci. 2006 Nov;24(9):2530-42. doi: 10.1111/j.1460-9568.2006.05149.x. Eur J Neurosci. 2006. PMID: 17100841 Free PMC article.

10

Blocking the apolipoprotein E/amyloid-beta interaction as a potential therapeutic approach for Alzheimer's disease.

Sadowski MJ, Pankiewicz J, Scholtzova H, Mehta PD, Prelli F, Quartermain D, Wisniewski T. Sadowski MJ, et al. Among authors: wisniewski t. Proc Natl Acad Sci U S A. 2006 Dec 5;103(49):18787-92. doi: 10.1073/pnas.0604011103. Epub 2006 Nov 20. Proc Natl Acad Sci U S A. 2006. PMID: 17116874 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

453 results

Search Page